IFNB1 and multiple sclerosis: In studies about multiple sclerosis it was shown that postmortem samples of the brain from multiple sclerosis patients expressed high levels of CD73 in the microvasculature; moreover enhanced levels of soluble serum CD73 activity and skin microvascular CD73 expression were observed after treatment with IFN-β [262,263].